Anavex Life Sciences Corp (AVXL)

[D-Mike]

I’m in that ballpark as well Falconer. My simple math is once were approved for Alzheimer’s and becomes a revenue generating biotech company, our market cap should be $10 billion or app $130/share. Throw in all of the other goodness we have in our pipeline and the share price is substantially higher. Take care my friend